Use of non-LDL-C lipid-lowering medications in patients with type 2 diabetes.

Suzanne V ArnoldKensey GoschNathan D WongVittal HejjajiAbhinav GoyalLawrence A LeiterMikhail Kosiborod

Published in: Endocrinology, diabetes & metabolism (2020)

As clinical trials demonstrate little to no cardiovascular benefit from taking these medications, greater attention is needed to focus the use of lipid-lowering medications to those with proven benefit.

Keyphrases

clinical trial
fatty acid
working memory
open label